Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)

Market Cap	1.07T
Revenue (ttm)	498.18B
Net Income (ttm)	80.13B
Shares Out	9.33M
EPS (ttm)	6,268.00
PE Ratio	18.27
Forward PE	n/a
Dividend	19,100.00 (16.68%)
Ex-Dividend Date	Feb 18, 2025

Volume	601
Average Volume	3,540
Open	111,000
Previous Close	111,700
Day's Range	111,000 - 114,500
52-Week Range	73,600 - 135,800
Beta	0.37
RSI	47.30
Earnings Date	Apr 18, 2025

About HNX:PMC

Pharmedic Pharmaceutical Medicinal Joint Stock Company engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam. The company offers non-prescription drug products for gastrointestinal and hepatobiliary; cardiovascular; respiratory; central nervous; skeletal; hormones; anti-infectives; urinary; endocrine and metabolic; vitamins and minerals; eye; ear – mouth/ throat; dermatologicals; allergy and immune; cardiovascular; diabetes; and other systems. It also pro...

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 534
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: PMC

Financial Performance

In 2024, HNX:PMC's revenue was 498.18 billion, an increase of 2.68% compared to the previous year's 485.19 billion. Earnings were 80.13 billion, an increase of 31.36%.